AB SCIEX Life Sciences Case Study© 2013 Dassault Systèmes Life Sciences Case Study: AB SCIEX 2 Proactively meeting regulatory challenges Rather than view RoHS as a looming regulatory nightmare, Valaitis saw tremendous potential in meeting this new challenge head on. In 2016 all of AB SCIEX’s medical device products will be subject to RoHS regulatory restrictions and in 2017, most of its other products will follow. However , Valaitis has p

Join for free to read